Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
5 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//PSYCHOLOGY, EXPERIMENTAL | 1830502 |
299 | 3 | PARKINSONS DISEASE//ALPHA SYNUCLEIN//MOVEMENT DISORDERS | 41610 |
141 | 2 | PARKINSONS DISEASE//MOVEMENT DISORDERS//LEVODOPA | 22884 |
13701 | 1 | ENTACAPONE//TOLCAPONE//COMT INHIBITORS | 849 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | ENTACAPONE | authKW | 4035327 | 18% | 70% | 155 |
2 | TOLCAPONE | authKW | 2227472 | 10% | 67% | 89 |
3 | COMT INHIBITORS | authKW | 1451843 | 7% | 66% | 59 |
4 | COMT INHIBITION | authKW | 1164558 | 5% | 78% | 40 |
5 | CATECHOL O METHYLTRANSFERASE | authKW | 714450 | 13% | 17% | 111 |
6 | CATECHOL O METHYLTRANSFERASE INHIBITOR | authKW | 558994 | 2% | 94% | 16 |
7 | OPICAPONE | authKW | 519691 | 2% | 100% | 14 |
8 | STALEVO | authKW | 348516 | 2% | 72% | 13 |
9 | NEBICAPONE | authKW | 337460 | 1% | 91% | 10 |
10 | 3 O METHYLDOPA | authKW | 289925 | 2% | 46% | 17 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Clinical Neurology | 2725 | 25% | 0% | 216 |
2 | Pharmacology & Pharmacy | 2659 | 34% | 0% | 285 |
3 | Neurosciences | 877 | 20% | 0% | 174 |
4 | Chemistry, Analytical | 529 | 12% | 0% | 102 |
5 | Biochemical Research Methods | 477 | 9% | 0% | 74 |
6 | Chemistry, Medicinal | 259 | 6% | 0% | 50 |
7 | Biochemistry & Molecular Biology | 113 | 14% | 0% | 119 |
8 | Psychiatry | 73 | 4% | 0% | 38 |
9 | Toxicology | 72 | 4% | 0% | 30 |
10 | Biophysics | 13 | 3% | 0% | 22 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | INVEST DESENVOLVIMENTO | 129916 | 1% | 50% | 7 |
2 | PRAKLIN FOR | 66809 | 1% | 30% | 6 |
3 | ORION | 39590 | 0% | 27% | 4 |
4 | MEDINUP | 38660 | 1% | 21% | 5 |
5 | AVANZATO BIOTECNOL | 37121 | 0% | 100% | 1 |
6 | BU NEUROL | 37121 | 0% | 100% | 1 |
7 | CALIF PARKINSON | 37121 | 0% | 100% | 1 |
8 | CANC BIOL SCI | 37121 | 0% | 100% | 1 |
9 | CANC CELL BIOLPROTE SECT DNR | 37121 | 0% | 100% | 1 |
10 | CHEM BIOL RUTGERS | 37121 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CLINICAL NEUROPHARMACOLOGY | 15664 | 4% | 1% | 32 |
2 | JOURNAL OF NEURAL TRANSMISSION | 6962 | 3% | 1% | 28 |
3 | AKTUELLE NEUROLOGIE | 4019 | 2% | 1% | 14 |
4 | JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION | 2644 | 0% | 2% | 4 |
5 | BIOMEDICAL CHROMATOGRAPHY | 2555 | 2% | 0% | 16 |
6 | PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION | 1621 | 1% | 1% | 5 |
7 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1473 | 2% | 0% | 17 |
8 | MOVEMENT DISORDERS | 1408 | 2% | 0% | 16 |
9 | EUROPEAN JOURNAL OF NEUROLOGY | 1329 | 1% | 0% | 12 |
10 | CNS DRUGS | 1300 | 1% | 0% | 8 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ENTACAPONE | 4035327 | 18% | 70% | 155 | Search ENTACAPONE | Search ENTACAPONE |
2 | TOLCAPONE | 2227472 | 10% | 67% | 89 | Search TOLCAPONE | Search TOLCAPONE |
3 | COMT INHIBITORS | 1451843 | 7% | 66% | 59 | Search COMT+INHIBITORS | Search COMT+INHIBITORS |
4 | COMT INHIBITION | 1164558 | 5% | 78% | 40 | Search COMT+INHIBITION | Search COMT+INHIBITION |
5 | CATECHOL O METHYLTRANSFERASE | 714450 | 13% | 17% | 111 | Search CATECHOL+O+METHYLTRANSFERASE | Search CATECHOL+O+METHYLTRANSFERASE |
6 | CATECHOL O METHYLTRANSFERASE INHIBITOR | 558994 | 2% | 94% | 16 | Search CATECHOL+O+METHYLTRANSFERASE+INHIBITOR | Search CATECHOL+O+METHYLTRANSFERASE+INHIBITOR |
7 | OPICAPONE | 519691 | 2% | 100% | 14 | Search OPICAPONE | Search OPICAPONE |
8 | STALEVO | 348516 | 2% | 72% | 13 | Search STALEVO | Search STALEVO |
9 | NEBICAPONE | 337460 | 1% | 91% | 10 | Search NEBICAPONE | Search NEBICAPONE |
10 | 3 O METHYLDOPA | 289925 | 2% | 46% | 17 | Search 3+O+METHYLDOPA | Search 3+O+METHYLDOPA |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |